Maharashtra, India

Anirban Mallik Thakur

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anirban Mallik Thakur: Innovator in Pharmaceutical Formulations

Introduction

Anirban Mallik Thakur is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stabilized cabazitaxel formulations. With a total of 3 patents to his name, Thakur is recognized for his innovative approaches to improving drug stability and administration.

Latest Patents

Thakur's latest patents focus on improved formulations for cabazitaxel. These formulations exhibit increased storage stability compared to other existing formulations. Additionally, they are designed to be simpler for healthcare providers to prepare and administer to patients. This innovation is crucial in enhancing patient care and ensuring the efficacy of treatments.

Career Highlights

Anirban Mallik Thakur is currently associated with Cipla Limited, a leading pharmaceutical company. His work at Cipla has allowed him to leverage his expertise in drug formulation and contribute to the development of effective pharmaceutical solutions. His dedication to innovation in the pharmaceutical industry has positioned him as a key figure in his field.

Collaborations

Thakur collaborates with talented professionals such as Geena Malhotra and Sarabjit Singh. These collaborations enhance the research and development efforts at Cipla, fostering an environment of innovation and excellence.

Conclusion

Anirban Mallik Thakur's contributions to pharmaceutical formulations, particularly in the area of cabazitaxel, highlight his role as an influential inventor. His work not only advances the field of medicine but also improves patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…